SARS-CoV-2-Specific Immune Responses to Vaccination in Children and Adolescents with Suppressed Immune Systems: A Prospective, Observational Study.

Saved in:
Bibliographic Details
Title: SARS-CoV-2-Specific Immune Responses to Vaccination in Children and Adolescents with Suppressed Immune Systems: A Prospective, Observational Study.
Authors: Brugha R; Cardiothoracic Transplantation, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom; National Institute for Health Research (NIHR) GOSH Biomedical Research Centre, London, United Kingdom. Electronic address: rossa.brugha@gosh.nhs.uk., Kirkham A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham Edgbaston, Birmingham, United Kingdom., Bate J; Department of Pediatric Oncology, University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom., Burke GAA; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham Edgbaston, Birmingham, United Kingdom; Department of Pediatric Oncology and Hematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Hughes A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham Edgbaston, Birmingham, United Kingdom., Magwaro S; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham Edgbaston, Birmingham, United Kingdom., Pope AM; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham Edgbaston, Birmingham, United Kingdom., Beesley R; Patient Representative for the OCTAVE Study, Juvenile Arthritis Research, Tonbridge, United Kingdom., Lax S; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham Edgbaston, Birmingham, United Kingdom., Kelly E; Department of Pediatrics, Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Greenland M; Department of Pediatrics, Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Minassian AM; Department of Pediatrics, Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; Department of Biochemistry, University of Oxford, Oxford, United Kingdom., Liu X; Department of Pediatrics, Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Billingham L; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham Edgbaston, Birmingham, United Kingdom., McInnes I; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, United Kingdom., Goodyear CS; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, United Kingdom., Kearns P; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham Edgbaston, Birmingham, United Kingdom., Wedderburn LR; National Institute for Health Research (NIHR) GOSH Biomedical Research Centre, London, United Kingdom; Pediatric Rheumatology, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom; Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Corporate Authors: OCTAVE-Minor Collaborative Group
Source: The Journal of pediatrics [J Pediatr] 2026 Feb; Vol. 289, pp. 114873. Date of Electronic Publication: 2025 Oct 24.
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 0375410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6833 (Electronic) Linking ISSN: 00223476 NLM ISO Abbreviation: J Pediatr Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-6833
DOI:10.1016/j.jpeds.2025.114873